CCN2 and Peritoneal Fibrosis: In experimental peritoneal fibrosis, lysophosphatidic acid (LPA) engages its receptor LPA1 to trigger cytoskeletal remodeling in mesothelial cells, promoting nuclear translocation of MRTF‐A/B and upregulation of connective tissue growth factor (CTGF).